HCSG 8-K Filed 2026-07-22 Execution disclosure

Healthcare Services Group repurchased $20.9M in Q2 under $75M plan

Company accelerated buyback pace in February 2026; has repurchased $44.9M year-to-date with 8.3M shares remaining.

MechanismNot specified

What the filing says

Healthcare Services Group reported Q2 2026 share repurchases of $20.9 million as part of a $75.0 million, 12-month share repurchase plan announced in February 2026. Year-to-date through the end of Q2, the company has repurchased $44.9 million of its common stock, leaving 8.3 million shares remaining under the authorization.

The company did not disclose the average price per share paid during the Q2 period or the execution mechanism (open-market purchases under Rule 10b-18, accelerated share repurchase, or other method). The buyback authorization runs through January 2027.

As of June 30, 2026, Healthcare Services Group had cash and marketable securities totaling $200.9 million and an unutilized $300.0 million credit facility, providing substantial liquidity to support ongoing repurchases and operational needs.

In February 2026, the Company announced its plan to further accelerate the pace of its share buybacks and repurchase $75.0 million of its common stock through January 2027. In the second quarter, the Company repurchased $20.9 million of its common stock. — HEALTHCARE SERVICES GROUP INC 8-K filing  ·  View on SEC EDGAR →

What this means

Healthcare Services Group's $75 million buyback authorization, announced in February 2026, represents an acceleration of the company's capital return strategy. With $44.9 million deployed through Q2 2026 against the $75 million authorization, the company is on track to substantially complete the program by the January 2027 deadline. The buyback reduces share count while the company maintains strong liquidity ($200.9 million in cash and securities plus $300 million available on its credit facility), suggesting confidence in operational cash generation despite inflationary pressures and labor-market challenges noted in healthcare services.</what_this_means> <parameter name="faqs">[{"question": "What was the authorization amount for this repurchase plan?", "answer": "In February 2026, Healthcare Services Group announced a plan to repurchase $75.0 million of its common stock through January 2027."}, {"question": "How much has the company repurchased so far?", "answer": "Year-to-date through Q2 2026, the company has repurchased $44.9 million of its common stock. In the second quarter alone, the company repurchased $20.9 million."}, {"question": "How many shares remain under authorization?", "answer": "The company has 8.3 million shares remaining under its February 2026 share repurchase authorization, though the authorization is stated in dollar terms ($75.0 million), not share count."}, {"question": "Does the filing disclose the average price paid per share?", "answer": "No, the filing does not disclose the average price paid per share in Q2 or year-to-date, nor does it specify the execution mechanism (Rule 10b-18 open-market purchases, accelerated share repurchase, or other method)."}, {"question": "What is the timeframe for this repurchase program?", "answer": "The authorization runs through January 2027, which represents approximately a 12-month program from the February 2026 announcement date."}, {"question": "Does the company have sufficient capital to complete the buyback?", "answer": "Yes, as of June 30, 2026, the company had cash and marketable securities of $200.9 million and an unutilized $300.0 million credit facility, providing substantial liquidity to fund the remaining ~$30 million in repurchases."}]

Frequently asked questions

execution healthcare-services rule-10b-18-or-unspecified mid-cap quarterly-earnings
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.